Immuno-oncology (IO) continues to redefine the future of cancer treatment in 2026, driving breakthroughs in checkpoint inhibitors, CAR-T therapies, bispecific antibodies, tumor microenvironment research, and biomarker-driven precision medicine. As the field rapidly evolves, global conferences have become essential platforms for collaboration between biotech leaders, pharma companies, clinicians, and researchers.
From academic-heavy meetings to industry-focused summits, 2026 offers a powerful lineup of immuno-oncology events across the USA, Europe, and global biotech hubs.
Below is a curated guide to the top immuno-oncology conferences in 2026—including key global meetings and why the Philadelphia-based Veridon Global Immuno-Oncology & Biomarker Summit 2026 stands out as a must-attend event.
Top Immuno-Oncology Conferences 2026 (Global Overview)
1. Veridon Global Immuno-Oncology & Biomarker Summit 2026 (Philadelphia, USA)
Location: Philadelphia, USA
Date: October 19–20, 2026
Organized by Veridon Global
The 2nd Immuno-Oncology and Biomarker Summit 2026 in Philadelphia is emerging as one of the most strategically positioned IO meetings in the USA, uniquely combining immuno-oncology innovation with biomarker-driven precision medicine. Unlike broader global conferences, this summit is highly focused on translational execution, bridging the gap between discovery science and real-world clinical implementation.
Why Philadelphia is Becoming a Key IO Hub
Philadelphia is home to leading academic hospitals, oncology research centers, and biotech ecosystems. This makes the city a natural convergence point for:
- Clinical oncology innovation
- Biomarker validation studies
- Early-phase drug development
- Industry–academic partnerships
Register now for the Immuno-Oncology & Biomarker Conference 2026 in Philadelphia
Secure early bird pricing and guaranteed access to high-impact sessions.
Sponsorship Opportunities Available
Position your brand at the forefront of immuno-oncology innovation and precision medicine.
2. AACR Immuno-Oncology Conference 2026 – USA
Location: Los Angeles, USA
Date February 18–21, 2026
Organized by the American Association for Cancer Research (AACR), this flagship event brings together leading scientists and clinicians to present cutting-edge research in immunotherapy, cancer vaccines, and translational oncology.
Key Focus:
- Immune checkpoint therapy
- Tumor immunology mechanisms
- Early clinical trials
- Cancer vaccines and cellular therapies
3. Immuno-Oncology 360° Summit 2026 – USA
Location: Boston, USA
Date: February 10–12, 2026
A major industry-driven conference connecting science, business, and investment communities in immuno-oncology.
Key Focus:
- IO drug development pipeline
- Biomarkers and diagnostics
- Cell therapy innovation
- Clinical development strategies
4. SITC Immuno-Oncology Drug Development Summit 2026 – Switzerland
Location: Lausanne, Switzerland
Date: September 3–4, 2026
A focused meeting led by the Society for Immunotherapy of Cancer (SITC), emphasizing translational research and clinical development.
Key Focus:
- CAR-T and T-cell therapies
- Bispecific antibodies
- IO combination strategies
- Regulatory and clinical trial design
5. ESMO Immuno-Oncology Congress 2026 – UK
Location: London, UK
Date: December 14–16, 2026
A globally recognized oncology congress focusing on clinical application of immunotherapies.
Key Focus:
- Real-world IO treatment outcomes
- Combination therapies
- Biomarkers in clinical practice
- Patient-centric oncology care
6. BIO International Convention 2026 – USA
Location: San Diego, USA
Date: June 22–25, 2026
While not IO-exclusive, BIO 2026 is the largest biotech partnering event globally, making it highly relevant for immuno-oncology companies.
Key Focus:
- Biotech partnerships
- Oncology drug pipelines
- AI and precision medicine
- Investment and licensing deals
What Makes the Veridon Global Summit Stand Out
Focused Dual-Track Structure
- Immuno-Oncology Innovation Track
- Biomarkers & Companion Diagnostics Track
Core Topics Include
- Next-generation immunotherapies (CAR-T, bispecific, ADCs)
- Tumor microenvironment & resistance mechanisms
- Liquid biopsy & minimal residual disease (MRD)
- AI-driven oncology and multi-omics integration
- Clinical translation of biomarkers into practice
Why It Matters
While larger conferences provide scale, the Philadelphia summit delivers depth, specificity, and actionable insights, making it ideal for:
- Pharma R&D leaders
- Biomarker scientists
- Clinical trial designers
- Diagnostic developers
- Precision oncology innovators
Global IO Conference Comparison (2026)
| Conference | Location | Strength | Best For |
| AACR IO 2026 | USA (Los Angeles) | Academic research depth | Scientists & translational researchers |
| IO360° 2026 | USA (Boston) | Industry + investment | Biotech & pharma executives |
| SITC Summit | Switzerland | Drug development focus | Clinical & regulatory teams |
| ESMO IO Congress | UK | Clinical application | Oncologists & healthcare systems |
| BIO 2026 | USA (San Diego) | Networking & partnerships | Investors & biotech leaders |
| Veridon Global IO Summit | USA (Philadelphia) | Biomarker + IO integration | Precision oncology & translational science |
Why You Should Attend the Philadelphia IO Summit 2026
The Veridon Global Immuno-Oncology & Biomarker Summit 2026 stands out because it addresses a critical gap in the IO ecosystem:
– turning biomarker science into real clinical decision-making.
With focused discussions on:
- AI in oncology
- Liquid biopsy applications
- Biomarker-driven therapy selection
- Next-generation IO combinations
It provides a high-impact environment for professionals who want practical, translational outcomes—not just theory.
Final Takeaway
Immuno-oncology in 2026 is no longer just about discovery, it is about translation, precision, and real-world implementation. While global conferences like AACR, ESMO, and BIO continue to dominate scale and visibility, specialized meetings like the Veridon Global Philadelphia Summit are becoming increasingly important for deep scientific progress.
If your goal is to stay ahead in immunotherapy innovation, biomarker development, and clinical translation, attending the right Immuno-oncology conference can define your year.
